Xenetic Biosciences, Inc.
Xenetic Biosciences, Inc.
FRAMINGHAM, MA
Loading...
Price History
Market Data
| Market Cap | 489,456.24 |
| P/E Ratio | - |
| P/B Ratio | 0.07 |
| EPS | - |
| Dividend Yield | - |
| D/E Ratio | 0.13 |
| Current Ratio | 8.32 |
| Currency | USD |
Key Financial Metrics
2.98M
Revenue
-2.68M
Net Income
-
EPS (Diluted)
-4.67M
Free Cash Flow
Profitability
Gross Margin
-
Operating Margin
-95.2%
Net Profit Margin
-90.1%
EBITDA
-2.83M
Returns & Efficiency
Return on Assets (ROA)
-32.1%
Return on Equity (ROE)
-36.2%
Dividend Yield
-
EPS
-
Financial Health
Total Assets
8.36M
Total Debt
-
Debt to Equity
0.13x
Current Ratio
8.32
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Chemicals & Allied Products |
| HQ | FRAMINGHAM, MA |
| Fiscal Year | 2025 |
Peers
LILLY ELI & CO
LLY
894.82B
P/E: --
ELI LILLY & CO
LLY
894.82B
P/E: --
533.28B
P/E: --
ABBVIE INC.
ABBV
355.49B
P/E: --
BEIGENE, LTD.
BEIGF
306.50B
P/E: 632.4
BEONE MEDICINES LTD.
BEIGF
306.50B
P/E: 632.4
275.14B
P/E: --
MERCK & CO. INC.
MRK
275.14B
P/E: --
Quick Links
Financial Statistics
Valuation
Market Cap$489.46K
P/E Ratio (TTM)-
Price to Book0.07
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin-
Operating Margin-95.2%
Net Margin-90.1%
ROE-36.2%
ROA-32.1%
Leverage & Liquidity
Debt to Equity0.13
Current Ratio8.32
Total Debt-
Total Assets$8.36M
Stockholders' Equity$7.40M
Income Statement (FY 2025)
Revenue$2.98M
Gross Profit-
Operating Income$-2.83M
Net Income$-2.68M
EPS (Diluted)-
Cash Flow (FY 2025)
Free Cash Flow$-4.67M
Cash & Equivalents-
Revenue Growth19.0%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | 945 CONCORD ST. FRAMINGHAM, MA 01701 |
| Phone | N/A |
| Incorporated | NV, US |
| EIN | 452952962 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 159,432.00 |
| Stockholders' Equity | $7.40M |
Recent Filings
View All
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-23
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2026-03-12
Local
SCHEDULE 13G
Passive Ownership Report
Schedule 13G - passive beneficial ownership
Filed: 2026-02-12
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-11-12
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2025-10-31
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-08-12
Local
10-K/A
Amended Annual Report
Amendment to previously filed annual report
Filed: 2025-05-13
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-05-13
Local
10-K/A
Amended Annual Report
Amendment to previously filed annual report
Filed: 2025-04-29
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2025-03-18
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2024-11-12
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2024-10-31
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2024-08-13
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2024-05-09
Local
10-K/A
Amended Annual Report
Amendment to previously filed annual report
Filed: 2024-04-26
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | Xenetic Biosciences, Inc. |
| Ticker | XBIO |
| Exchange | -- |
| Sector | Manufacturing |
| Industry | Chemicals & Allied Products |
| Headquarters | FRAMINGHAM, MA |
| Fiscal Year | 2025 |
Financial Summary
| Market Cap | 489,456.24 |
| Revenue | 2.98M |
| Net Income | -2.68M |
| P/E Ratio | - |
| EPS | - |
| Net Margin | -90.1% |
| ROE | -36.2% |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...